EU

Showing 15 posts of 252 posts found.

EU votes for tighter internet drug regulations

May 4, 2010
Sales and Marketing EU, counterfeits, viagra

The European Parliament has voted to enact stronger legislation against poor quality medicines available on the internet. The move comes …

European regulators begin Tysabri review

October 26, 2009
Sales and Marketing EU, Tysabri, reg

European regulators have begun a risk-benefit review of Biogen Idec’s multiple sclerosis drug Tysabri, which has been linked to 23 …

EFPIA starts anti-counterfeiting pilots in Sweden

October 21, 2009
Manufacturing and Production, Sales and Marketing EU, counterfeits, supply chain

More than 100,000 products and 25 retail pharmacies in Stockholm will take part in a two-month anti-counterfeiting project run by …

European pharma companies raided

October 7, 2009
Sales and Marketing EU, reg

Several pharma companies have been raided as part of ongoing European Commission investigations into competitiveness issues. Sanofi-Aventis, Novartis and generic …

Europe warns pharma about further competition probes

October 1, 2009
Sales and Marketing EU, antitrust investigation, reg

The European Commission has warned the industry a new round of antitrust probes will be coming soon, just as the …

Europe approves two swine-flu vaccines

September 30, 2009
Sales and Marketing EU, GSK, Novartis, h1n1

The European Commission has approved the use of two vaccines for the pandemic H1N1 virus, commonly known as swine flu. …

Safety First

September 22, 2009
Research and Development, Sales and Marketing EU, US, reg, safety

A series of high-profile drug withdrawals in recent years has brought safety concerns to the fore, prompting more rigorous monitoring …

End of the line for European paracetamol

January 12, 2009
Manufacturing and Production EU

The last European plant manufacturing paracetamol closed for the final time at the turn of the year, another sign that …

The Pharmafocus Interview: Elmar Schnee

January 6, 2009
Sales and Marketing EU, Germany, IQWIG, Merck Serono, cost-effectiveness

Germany's Merck has the kind of business model that investors warm to during times of recession. The company is the …

Abraxis Biosciences launches Abraxane in Europe

January 2, 2009
Sales and Marketing Abraxis, Cancer, EU

US biotech company Abraxis BioScience has launched its innovative breast cancer treatment Abraxane in Europe. The drug is a variant …

Commission to reveal anti-competitive probe findings

November 27, 2008
Sales and Marketing EU, reg

The European pharmaceutical industry could shortly face a major inquiry into its practices, with the European Commission ready to reveal …

The Gateway to Local Adoption Series

Latest content